Taking into account that large trials on RAAS-blockade in diabetic nephropathy have shown a similar effect size, this was a highly significant finding for ADPKD patients [ 86–89 ].
← all excerpts
Management of autosomal-dominant polycystic kidney disease-state-of-the-art.
1
—
—